Who owns GeneDx Holdings Corp. (SMFR)? Elite investor 13F holders

3 tracked elite investors reported holding GeneDx Holdings Corp as of 2026-06-30, including Corvex Management, Tudor Investment, D.E. Shaw. Who bought, trimmed or exited each quarter, with links to the original SEC 13F filings.

3 tracked investors currently reported holding · Latest report period: 2026-06-30 · Health Care · Health Care Equipment & Services

GeneDx Holdings Corp., a genomics company, provides genetic testing services. The company primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as well as data and information services. It also develops an AI-based platform for next generation sequencing analysis, interpretation, and clinical reporting for rare disease, hereditary risk, and…

Reported holders and securities, including exits (up to 20)

Reported holders and securities, including exits (up to 20)
InvestorSecurityInstrumentReport periodFiledValueQuantityUnitsChangeSource
Corvex ManagementGENEDX HOLDINGS CORPSHARE2026-06-302026-08-14 00:00:00328460731.00 USD4784570.000000SharesaddOriginal filing
Renaissance Technologies LLCGENEDX HOLDINGS CORPSHARE2026-06-302026-08-13 00:00:000.00 USD0.000000SharesexitedOriginal filing
Tudor InvestmentGENEDX HOLDINGS CORPSHARE2026-06-302026-08-14 00:00:007471797.00 USD108839.000000SharesaddOriginal filing
Polen Capital ManagementGENEDX HOLDINGS CORPSHARE2026-06-302026-08-04 00:00:000.00 USD0.000000SharesexitedOriginal filing
D.E. ShawGENEDX HOLDINGS CORPSHARE2026-06-302026-08-14 00:00:002668906.00 USD38877.000000SharesaddOriginal filing
D.E. ShawGENEDX HOLDINGS CORPSHARE2026-06-302026-08-14 00:00:001355.00 USD467197.000000SharesholdOriginal filing

Public disclosures can be delayed, incomplete, or amended. Report period describes a position date; transaction date describes a reported transaction; filed describes submission. A recent filing or page update does not establish a current holding. A dash means unavailable or not comparable, not zero.

This public summary shows the default reporting scope. Enable JavaScript for interactive filters, charts, and additional rows.

How to read the data · Disclaimer

Read as Markdown